ArticleKidney international reports2018
Emphysematous Pyelonephritis Case Series From South India.
Article in Kidney international reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.
- Prevalence and Risk Factors of Mortality in Emphysematous Pyelonephritis Patients: A Meta-Analysis.World journal of surgery · 2022Pooled it
- A systematic review and meta-analysis of risk factors and treatment choices in emphysematous pyelonephritis.International urology and nephrology · 2022Pooled it
- Analysis of Pathogenic Bacteria, Drug Resistance and Treatment of Emphysematous Pyelonephritis: A Case Series.Infection and drug resistance · 2026Article
- Medical management of emphysematous pyelonephritis: a case report.Annals of medicine and surgery (2012) · 2025Article
- 'Case of the Month' from the First Hospital of Sanming, Fujian Medical University, China: management of a renal haematoma with pyelonephritis and necrotising fasciitis.BJU international · 2025Article
- Identifying predictors of in-hospital mortality in patients with emphysematous pyelonephritis: insights from a large retrospective cohort.World journal of urology · 2025Article
- Article
- Case Report: Massive emphysematous pyelonephritis with short-term relapse.Frontiers in medicine · 2025Article
- Emphysematous pyelonephritis caused by Raoultella ornithinolytica: a case report.BMC nephrology · 2024Article
- Report on the diagnosis and treatment of 3 cases of emphysematous pyelonephritis with two different outcomes.Frontiers in medicine · 2024Article
- Article
- Emphysematous pyelonephritis: Six case reports and review of literature.World journal of clinical cases · 2022Article
- Emphysematous Pyelonephritis with IgA-Dominant Infection-Related Glomerulonephritis: An Unusual Picture.Acta medica academica · 2022Article
- Point-of-care ultrasound for the early diagnosis of emphysematous pyelonephritis: A case report and literature review.World journal of clinical cases · 2021Article
- Diabetic ketoacidosis complicated by emphysematous pyelonephritis: a case report and literature review.BMC urology · 2020Review
- Emphysematous Pyelonephritis: A single center review.Pakistan journal of medical sciences · 2020Article
- Emphysematous pyelonephritis treatment strategies in correlation to the CT classification: have the current experience and prognosis changed?International urology and nephrology · 2019Article
- Emphysematous Pyelonephritis Presenting as Pneumaturia and the Use of Point-of-Care Ultrasound in the Emergency Department.Case reports in emergency medicine · 2019Article
- Emphysematous pyelonephritis: classification, management, and prognosis.Tzu chi medical journalReview
- A Prospective study of Emphysematous Pyelonephritis in Patients with Type 2 Diabetes.Indian journal of nephrologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionEmphysematous pyelonephritis (EPN) is a rare, life-threatening necrotizing infection of the kidney. The mortality rate for EPN is as high as 25%. We conducted a retrospective study at MS Ramaiah Hospital between January 2011 and May 2016 to observe the clinical, biochemical, and microbiological patterns of EPN at our institute.
methodsThe clinical and laboratory data, imaging findings, and microbiological patterns of 51 patients chosen for the study were recorded. The data were analyzed to identify the prognostic variables that could predict the morbidity and mortality of patients with EPN, and the focus of this study was to determine risk factors for and outcomes of patients who presented with EPN and who required hemodialysis. Primary endpoints were successful treatment and all-cause mortality. Secondary endpoints included need for hemodialysis and the need for a specific treatment.
resultsThere was an equal incidence among both sexes (median age: 59 years). Common symptoms were abdominal pain (94.11%), fever (83.2%), dysuria (74.5%), vomiting (72.54%), frequency of micturition (68.62%), oliguria, generalized weakness (66.67%), and breathlessness (66.67%); 98.03% (n = 50) of the patients had diabetes. The most common organism cultured was
conclusionEarly diagnosis and broad spectrum antibiotics, together with an appropriately timed intervention, resulted in decreased mortality. Pain in the abdomen and renal angle tenderness were the most common clinical finding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.